Liver transplantation for hepatocellular cancer: UCL experience in 137 adult cirrhotic patients. Alpha-foetoprotein level and locoregional treatment as refined selection criteria
Open Access
- 20 June 2012
- journal article
- research article
- Published by Frontiers Media SA in Transplant International
- Vol. 25 (8), 867-875
- https://doi.org/10.1111/j.1432-2277.2012.01512.x
Abstract
Liver transplantation (LT) is a validated treatment for selected cirrhotics with hepatocellular cancer (HCC). A retrospective single center study including 137 recipients having proven HCC was done to refine inclusion criteria for LT as well as to look at impact of locoregional treatment (LRT) on outcome. At pre-LT imaging, 42 (30.6%) patients were Milan criteria (MC)-OUT; 28 (20.4%) were University of California San Francisco criteria (UCSFC)-OUT. Pre-LT LRT was performed in 109 (79.6%) patients. Multivariate analysis identified four factors to be independently predictive of recurrence: tumour number >3, AFP level ≥400 ng/ml, microvascular invasion and rejection needing anti-lymphocytic antibodies. When considering pre-transplant variables only, AFP level ≥400 ng/ml (HR = 5.13; P < 0.0001) was the unique risk factor for recurrence; conversely, application of LRT was protective (HR = 0.42; P = 0.04). MC-IN patients having LRT (n = 79) had the best 5-year tumour-free survival (TFS) (91.6%). MC-IN patients without LRT (n = 16) and MC-OUT patients with LRT (n = 30) had similar good TFS (72.7% vs.77.5%); finally MC-OUT patients without LRT (n = 12) had the worst results (45.0%; vs. 1st group: P < 0.0001). Immediate pre-LT AFP and aggressive pre-transplant LRT strategy, especially in MC-OUT patients, are both important elements to further expand inclusion criteria without compromising long-term results of HCC liver recipients.Keywords
This publication has 35 references indexed in Scilit:
- Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume centerLiver Transplantation, 2008
- Intention-to-Treat Analysis of Liver Transplantation in Selected, Aggressively Treated HCC Patients Exceeding the Milan CriteriaAmerican Journal of Transplantation, 2007
- Liver transplantation for hepatocellular carcinomaGastroenterology, 2004
- Competing Risks Analysis of Predictors of Delisting Owing to Tumor Progression in Liver Transplant Candidates with Hepatocellular CarcinomaAmerican Journal of Transplantation, 2004
- Hepatocellular carcinomaThe Lancet, 2003
- Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic ConferenceHepatology, 2003
- Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survivalHepatology, 2001
- Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome-oriented decision analysisHepatology, 2000
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine, 1996
- Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patientsWorld Journal of Surgery, 1991